Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?

MLA

Robert G. Micheletti, et al. “Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?” American Journal of Clinical Dermatology, vol. 22, Jan. 2021, pp. 139–47. EBSCOhost, https://doi.org/10.1007/s40257-020-00579-z.

APA

Robert G. Micheletti, Michelle A. Lowes, Tasnim Abdalla, Afsaneh Alavi, A. Hillary Steinhart, & Nirmal Kaur. (2021). Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors? American Journal of Clinical Dermatology, 22, 139–147. https://doi.org/10.1007/s40257-020-00579-z

Chicago

Robert G. Micheletti, Michelle A. Lowes, Tasnim Abdalla, Afsaneh Alavi, A. Hillary Steinhart, and Nirmal Kaur. 2021. “Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?” American Journal of Clinical Dermatology 22 (January): 139–47. doi:10.1007/s40257-020-00579-z.